- Home
- MRAM vs PROK Comparison
MRAM vs PROK Comparison
Compare MRAM & PROK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRAM
- PROK
- Stock Information
- Founded
- MRAM 2008
- PROK 2015
- Country
- MRAM United States
- PROK United States
- Employees
- MRAM N/A
- PROK N/A
- Industry
- MRAM Semiconductors
- PROK Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MRAM Technology
- PROK Health Care
- Exchange
- MRAM Nasdaq
- PROK Nasdaq
- Market Cap
- MRAM 114.4M
- PROK 94.9M
- IPO Year
- MRAM 2016
- PROK N/A
- Fundamental
- Price
- MRAM $5.94
- PROK $0.72
- Analyst Decision
- MRAM Strong Buy
- PROK Buy
- Analyst Count
- MRAM 2
- PROK 4
- Target Price
- MRAM $9.00
- PROK $5.00
- AVG Volume (30 Days)
- MRAM 73.3K
- PROK 1.1M
- Earning Date
- MRAM 04-30-2025
- PROK 05-16-2025
- Dividend Yield
- MRAM N/A
- PROK N/A
- EPS Growth
- MRAM N/A
- PROK N/A
- EPS
- MRAM N/A
- PROK N/A
- Revenue
- MRAM $49,110,000.00
- PROK $76,000.00
- Revenue This Year
- MRAM $8.07
- PROK N/A
- Revenue Next Year
- MRAM $17.98
- PROK N/A
- P/E Ratio
- MRAM N/A
- PROK N/A
- Revenue Growth
- MRAM N/A
- PROK N/A
- 52 Week Low
- MRAM $4.34
- PROK $0.46
- 52 Week High
- MRAM $7.00
- PROK $4.44
- Technical
- Relative Strength Index (RSI)
- MRAM 66.98
- PROK 42.92
- Support Level
- MRAM $5.57
- PROK $0.94
- Resistance Level
- MRAM $6.15
- PROK $0.77
- Average True Range (ATR)
- MRAM 0.25
- PROK 0.12
- MACD
- MRAM 0.07
- PROK -0.01
- Stochastic Oscillator
- MRAM 80.37
- PROK 21.71
About MRAM Everspin Technologies Inc.
Everspin Technologies Inc is a provider of Magnetoresistive Random Access Memory (MRAM) products. Its portfolio of MRAM technologies, including Toggle MRAM and Spin-transfer Torque MRAM (STT-MRAM), delivers superior performance, persistence, and reliability in non-volatile memories that transform how mission-critical data is protected against power loss. The company derives revenue from the sale of MRAM-based products in discrete unit form, licenses of and royalties on MRAM and magnetic sensor technology, the sale of backend foundry services, and design services to third parties. It recognizes revenue in three primary geographic regions; North America; Europe, the Middle East, and Africa (EMEA) and Asia-Pacific (APAC).
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.